Herdman MT et al. |
The role of previously unmeasured organic acids in the pathogenesis of severe malaria. |
2015 |
Crit Care |
pmid:26343146
|
Pavlou E et al. |
An infant with ethylmalonic encephalopathy masquerading as a hematologic disorder. |
2013 |
J. Child Neurol. |
pmid:22805253
|
Schuck PF et al. |
Ethylmalonic acid modulates Na+, K(+)-ATPase activity and mRNA levels in rat cerebral cortex. |
2013 |
Synapse |
pmid:23161776
|
Amaral AU et al. |
Ethylmalonic acid impairs brain mitochondrial succinate and malate transport. |
2012 |
Mol. Genet. Metab. |
pmid:22133302
|
Dweikat I et al. |
Ethylmalonic encephalopathy associated with crescentic glomerulonephritis. |
2012 |
Metab Brain Dis |
pmid:22584649
|
Gallant NM et al. |
Biochemical, molecular, and clinical characteristics of children with short chain acyl-CoA dehydrogenase deficiency detected by newborn screening in California. |
2012 |
Mol. Genet. Metab. |
pmid:22424739
|
Tomlinson L et al. |
Cannabinoid receptor antagonist-induced striated muscle toxicity and ethylmalonic-adipic aciduria in beagle dogs. |
2012 |
Toxicol. Sci. |
pmid:22821849
|
Schmidt SP et al. |
Toxic response caused by a misfolding variant of the mitochondrial protein short-chain acyl-CoA dehydrogenase. |
2011 |
J. Inherit. Metab. Dis. |
pmid:21170680
|
Westermann CM et al. |
Decreased oxidative phosphorylation and PGAM deficiency in horses suffering from atypical myopathy associated with acquired MADD. |
2011 |
Mol. Genet. Metab. |
pmid:21843962
|
Linster CL et al. |
Ethylmalonyl-CoA decarboxylase, a new enzyme involved in metabolite proofreading. |
2011 |
J. Biol. Chem. |
pmid:22016388
|
Zolkipli Z et al. |
Vulnerability to oxidative stress in vitro in pathophysiology of mitochondrial short-chain acyl-CoA dehydrogenase deficiency: response to antioxidants. |
2011 |
PLoS ONE |
pmid:21483766
|
Rodenburg RJ |
Biochemical diagnosis of mitochondrial disorders. |
2011 |
J. Inherit. Metab. Dis. |
pmid:20440652
|
Bosch AM et al. |
Brown-Vialetto-Van Laere and Fazio Londe syndrome is associated with a riboflavin transporter defect mimicking mild MADD: a new inborn error of metabolism with potential treatment. |
2011 |
J. Inherit. Metab. Dis. |
pmid:21110228
|
Barth M et al. |
Multiple sources of metabolic disturbance in ETHE1-related ethylmalonic encephalopathy. |
2010 |
J. Inherit. Metab. Dis. |
pmid:20978941
|
Schuck PF et al. |
Promotion of lipid and protein oxidative damage in rat brain by ethylmalonic acid. |
2010 |
Neurochem. Res. |
pmid:19757035
|
van Maldegem BT et al. |
Flavin adenine dinucleotide status and the effects of high-dose riboflavin treatment in short-chain acyl-CoA dehydrogenase deficiency. |
2010 |
Pediatr. Res. |
pmid:19952864
|
Pedersen CB et al. |
Antioxidant dysfunction: potential risk for neurotoxicity in ethylmalonic aciduria. |
2010 |
J. Inherit. Metab. Dis. |
pmid:20443061
|
Viscomi C et al. |
Combined treatment with oral metronidazole and N-acetylcysteine is effective in ethylmalonic encephalopathy. |
2010 |
Nat. Med. |
pmid:20657580
|
Chae JH et al. |
Risk factors of ocular involvement in children with mitochondrial respiratory chain complex defect. |
2010 |
Korean J Pediatr |
pmid:21253313
|
DiMauro S |
Pathogenesis and treatment of mitochondrial myopathies: recent advances. |
2010 |
Acta Myol |
pmid:21314015
|